drugset / Trial / NCT00174421

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

NCT00174421

Phase 3 Completed 36 enrolled Pfizer
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age

Timeline

Start
2001-04
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic

Indications

No indication recorded.